Journey to Narayama: cultural complexities, psychedelics and dementia
In their target article, Peterson et al. discuss the intriguing prospect of using psychedelics as a treatment for patients with Alzheimer’s Disease and Related Dementias (AD/ADRD) (Peterson et al. Citation2023). They provide a helpful analysis of ethical issues that may arise in research or clinical...
Main Authors: | Ozeki-Hayashi, R, Wilkinson, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Taylor & Francis
2023
|
Similar Items
-
Psychedelics as a Treatment for Alzheimer’s Disease Dementia
by: Simon Andrew Vann Jones, et al.
Published: (2020-08-01) -
Corrigendum: Psychedelics as a Treatment for Alzheimer's Disease Dementia
by: Simon Andrew Vann Jones, et al.
Published: (2020-10-01) -
Excusing psychedelics and accommodating psychedelics
by: Jacobs, E
Published: (2024) -
Psychedelic Psychiatry
by: D. Nutt
Published: (2022-06-01) -
Culture, context, and community in contemporary psychedelic research
by: Earp, BD, et al.
Published: (2021)